{
    "clinical_study": {
        "@rank": "129440", 
        "brief_summary": {
            "textblock": "Objectives: (1) To determine the incidence of lower-extremity lymphedema after staging\n      surgery for endometrial cancer; (2) to describe lymphedema-related morbidity after staging\n      surgery for endometrial cancer and (3) to evaluate pre- and post-operative quality of life\n      in women with endometrial cancer who undergo staging surgery.\n\n      Data analysis and risk/safety issues:  The proposed study will consist of a convenience\n      sample of women who undergo minimally invasive surgery for endometrial cancer over a 1 year\n      period.  The investigators anticipate enrollment of 75 to 100 women. Frequency tables and\n      difference with its 95% exact confidence intervals between pre-and post-operative lower\n      extremity lymphedema measurements and quality of life questionnaires will be estimated."
        }, 
        "brief_title": "Lymphedema in Endometrial Cancer", 
        "condition": [
            "Lower Extremity Lymphedema", 
            "Endometrial Cancer"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Endometrial Neoplasms", 
                "Sarcoma, Endometrial Stromal", 
                "Lymphedema"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. women older than 18 years old,\n\n          2. endometrial cancer,\n\n          3. suitable candidates for surgery,\n\n          4. scheduled to undergo laparoscopy or robotic-assisted (RA) laparoscopy for endometrial\n             cancer at Duke University Medical Center (DUMC),\n\n          5. no severe physical or mental comorbidity\n\n        Exclusion Criteria:\n\n          1. metastatic disease,\n\n          2. laparotomy"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "(1) women older than 18 years old, (2) endometrial cancer, (3) suitable candidates for\n        surgery, (4) scheduled to undergo laparoscopy or robotic-assisted (RA) laparoscopy for\n        endometrial cancer at Duke University Medical Center (DUMC), (5) no severe physical or\n        mental comorbidity"
            }
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 31, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01914276", 
            "org_study_id": "Pro00047483"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "January 21, 2014", 
        "location": {
            "contact": {
                "email": "laura.havrilesky@duke.edu", 
                "last_name": "Laura Havrilesky, MD", 
                "phone": "919-684-0126"
            }, 
            "contact_backup": {
                "last_name": "Micael Lopez, MD", 
                "phone": "919-684-8111"
            }, 
            "facility": {
                "address": {
                    "city": "Durham", 
                    "country": "United States", 
                    "state": "North Carolina", 
                    "zip": "27710"
                }, 
                "name": "Duke University Medical Center"
            }, 
            "investigator": {
                "last_name": "Laura Havrilesky, MD, MPH", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "A Pilot Study of Postoperative Lower-extremity Lymphedema and Quality of Life Among Women Undergoing Endometrial Cancer Staging Surgery", 
        "other_outcome": {
            "description": "The study team plans to measure QoL via 2 questionnaires, specifically the EQ-5D and FACT-G. FACT-G and EQ-5D-derived utility scores will be calculated and summarized pre- and post-operatively for all patients using descriptive statistics (means, medians, ranges).  The difference with 95% exact confidence intervals between pre- and post-operative FACT-G scores and EQ-5D utility scores obtained at each post-operative visit (t1 & t2) will be estimated.", 
            "measure": "change in quality of life in women with endometrial cancer who undergo staging surgery", 
            "safety_issue": "No", 
            "time_frame": "pre-operatively, 1 month post-op, and 6-9 months post-op"
        }, 
        "overall_contact": {
            "email": "micael.lopez@duke.edu", 
            "last_name": "Micael Lopez, MD", 
            "phone": "919 684 8111"
        }, 
        "overall_contact_backup": {
            "email": "jessie.ehrisman@duke.edu", 
            "last_name": "Jessie Ehrisman, BA", 
            "phone": "919 684 9065"
        }, 
        "overall_official": {
            "affiliation": "Duke University", 
            "last_name": "Laura Havrilesky, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "change in incidence of lower-extremity lymphedema", 
            "safety_issue": "No", 
            "time_frame": "1 month and 6-9 months after staging surgery for endometrial cancer"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01914276"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "change in lymphedema-related morbidity", 
            "safety_issue": "No", 
            "time_frame": "1 month and 6-9 months after staging surgery for endometrial cancer"
        }, 
        "source": "Duke University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Duke University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "January 2014"
    }
}